Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...
Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. MASH is the updated term for ...
Madrigal Pharmaceuticals (MASH) has reached an exclusive licensing agreement with China-based Suzhou Ribo Life Science to jointly develop treatments targeting a liver disease called metabolic ...
For just the fifth time in history, one of the rarest and most coveted American whiskeys is hitting shelves. Michter’s Celebration Sour Mash Whiskey will go on sale in February 2026—in extraordinarily ...
MASLD/MASH represents a growing clinical and economic burden, with MASH conferring heightened risks of advanced fibrosis, cirrhosis, hepatocellular carcinoma, and liver-related mortality. Noninvasive ...
Bud Cort, a seasoned actor best known for playing the lead role in the 1971 classic film “Harold and Maude,” has died. He was 77. A representative for his family told The New York Times that Cort died ...
If you happen to have some leftover mash or pick up a pack from the reduced section of the supermarket, these crispy, cheesy potato cakes are the perfect thing to make! Each potato cake provides 138 ...
Metabolic dysfunction-associated steatohepatitis (MASH), formerly nonalcoholic steatohepatitis (NASH), involves liver fat buildup that triggers inflammation and damage. The name change aims to be more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results